logo
Plus   Neg
Share
Email

Nutrien Issues 2020 Earnings Guidance - Quick Facts

Nutrien Ltd. (NTR,NTR.TO) said, for 2020, it expects adjusted net earnings of $1.90 to $2.60 per share and adjusted EBITDA of $3.8 billion to $4.3 billion. Analysts polled by Thomson Reuters expect the company to report profit per share of $3.04. Analysts' estimates typically exclude special items.

Fourth-quarter adjusted net earnings was $0.09 per share. On average, ten analysts polled by Thomson Reuters expected the company to report profit per share of $0.29, for the quarter. Adjusted EBITDA declined 28% to $664 million from previous year.

Fourth-quarter sales declined 9% year-on-year to $3.44 billion. Analysts expected revenue of $3.99 billion for the quarter.

Shares of Nutrien Ltd. were down 3% after hours.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
RELATED NEWS
Follow RTT